Sysmex Inostics Opens Cancer Research Excellence Program for Submissions
Sysmex Inostics industry-leading sensitivity for liquid biopsy
Sysmex Inostics Exhibits at Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoe...
Role of PD-1/PD-L1 pathway in the development of Head and neck squamous cell carcinoma (HNSCC)
Key differences between HPV-positive and HPV-negative head and neck squamous cell carcinomas (HNSCC)
Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022
Sysmex Inostics Expands Blood Test Offerings for Detection of Acute Myeloid Leukemia
Sysmex Inostics Introduces CLIA-Validated Highly Sensitive HNSCC-SEQ Testing Services for Head and Nec...
